lidocaine has been researched along with Neuromuscular Blockade in 23 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Neuromuscular Blockade: The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The addition of lidocaine to Magnesium Sulfate did not influence the cisatracurium neuromuscular blockade." | 9.41 | Lidocaine combined with magnesium sulfate preserved hemodynamic stability during general anesthesia without prolonging neuromuscular blockade: a randomized, double-blind, controlled trial. ( de Boer, HD; Garcia, LV; Oliveira-Paula, GH; Paula-Garcia, WN, 2021) |
| "We investigated vecuronium-induced neuromuscular blockade in patients with continuous epidural lidocaine injection and those without epidural lidocaine." | 7.72 | [Influence of epidural lidocaine injection on vecuronium-induced neuromuscular blockade]. ( Kakishita, M; Munakata, K; Nagai, H; Ogawa, S; Saeki, S; Suzuki, T; Watanabe, N, 2004) |
| "Neuromuscular blockade was evaluated with accelerometry, which measured a train-of-four (TOF) pattern of abductor policies muscle." | 6.70 | [Pretreatment with lidocaine accelerates onset of vecuronium-induced neuromuscular blockade]. ( Kumazawa, T; Masamune, T; Nonaka, A; Sugawara, T; Suzuki, S, 2002) |
| " The addition of lidocaine to Magnesium Sulfate did not influence the cisatracurium neuromuscular blockade." | 5.41 | Lidocaine combined with magnesium sulfate preserved hemodynamic stability during general anesthesia without prolonging neuromuscular blockade: a randomized, double-blind, controlled trial. ( de Boer, HD; Garcia, LV; Oliveira-Paula, GH; Paula-Garcia, WN, 2021) |
| "A continuous intravenous infusion of lidocaine has no impact on the time course of the neuromuscular blockade induced by a standard intubation dose of rocuronium." | 5.16 | Intravenous lidocaine has no impact on rocuronium-induced neuromuscular block. Randomised study. ( Czarnetzki, C; Elia, N; Lysakowski, C; Tramèr, MR, 2012) |
| "We investigated vecuronium-induced neuromuscular blockade in patients with continuous epidural lidocaine injection and those without epidural lidocaine." | 3.72 | [Influence of epidural lidocaine injection on vecuronium-induced neuromuscular blockade]. ( Kakishita, M; Munakata, K; Nagai, H; Ogawa, S; Saeki, S; Suzuki, T; Watanabe, N, 2004) |
| "Pregnancy has been reported to enhance the sensitivity of nerves to local anesthetics and to decrease anesthetic requirements during regional anesthesia." | 2.71 | Does pregnancy increase the efficacy of lumbar epidural anesthesia? ( Arakawa, M, 2004) |
| "Neuromuscular blockade was evaluated with accelerometry, which measured a train-of-four (TOF) pattern of abductor policies muscle." | 2.70 | [Pretreatment with lidocaine accelerates onset of vecuronium-induced neuromuscular blockade]. ( Kumazawa, T; Masamune, T; Nonaka, A; Sugawara, T; Suzuki, S, 2002) |
| "Oromandibular dystonia (OMD) is a focal dystonia manifested by involuntary masticatory and/or lingual muscle contractions." | 1.31 | Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology. ( Iizuka, T; Kaji, R; Shibasaki, H; Yoshida, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 4 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Ida, KK | 1 |
| Van-Wijnsberghe, AS | 1 |
| Tutunaru, A | 1 |
| Limpens, V | 1 |
| Sauvage, A | 1 |
| Serteyn, D | 1 |
| Sandersen, C | 1 |
| Krag, AE | 1 |
| Glick, S | 1 |
| Hembd, A | 1 |
| Rozen, SM | 1 |
| Paula-Garcia, WN | 1 |
| Oliveira-Paula, GH | 1 |
| de Boer, HD | 1 |
| Garcia, LV | 1 |
| Scherrer, NM | 1 |
| Hopster, K | 1 |
| Kumar, N | 1 |
| Sardana, R | 1 |
| Kaur, R | 1 |
| Jain, A | 1 |
| Taha, SK | 1 |
| El-Khatib, MF | 1 |
| Baraka, AS | 1 |
| Haidar, YA | 1 |
| Abdallah, FW | 1 |
| Zbeidy, RA | 1 |
| Siddik-Sayyid, SM | 1 |
| Light, S | 1 |
| Hans, GA | 1 |
| Defresne, A | 1 |
| Ki, B | 1 |
| Bonhomme, V | 1 |
| Kaba, A | 1 |
| Legrain, C | 1 |
| Brichant, JF | 1 |
| Hans, PC | 1 |
| Gill, VS | 1 |
| Presland, AH | 1 |
| Lord, JA | 1 |
| Bunce, C | 1 |
| Xing, W | 1 |
| Charteris, DG | 1 |
| Mahdy, RA | 1 |
| Ghanem, MT | 1 |
| Czarnetzki, C | 1 |
| Lysakowski, C | 1 |
| Elia, N | 1 |
| Tramèr, MR | 1 |
| Riad, W | 1 |
| Ahmad, N | 1 |
| Kumar, CM | 1 |
| Malinovsky, JM | 1 |
| Charles, F | 1 |
| Baudrimont, M | 1 |
| Péréon, Y | 1 |
| Le Corre, P | 1 |
| Pinaud, M | 1 |
| Benhamou, D | 1 |
| Nonaka, A | 1 |
| Sugawara, T | 1 |
| Suzuki, S | 1 |
| Masamune, T | 1 |
| Kumazawa, T | 1 |
| Yoshida, K | 1 |
| Kaji, R | 1 |
| Shibasaki, H | 1 |
| Iizuka, T | 1 |
| FOSTER, PA | 1 |
| Arakawa, M | 1 |
| Munakata, K | 1 |
| Suzuki, T | 1 |
| Watanabe, N | 1 |
| Nagai, H | 1 |
| Kakishita, M | 1 |
| Saeki, S | 1 |
| Ogawa, S | 1 |
| Kanai, A | 1 |
| Hoka, S | 1 |
| Ma, OJ | 1 |
| Atchley, RB | 1 |
| Hatley, T | 1 |
| Green, M | 1 |
| Young, J | 1 |
| Brady, W | 1 |
| Guise, P | 1 |
| Laurent, S | 1 |
| Gerner, P | 1 |
| Nakamura, T | 1 |
| Quan, CF | 1 |
| Anthony, DC | 1 |
| Wang, GK | 1 |
| Uy, HS | 1 |
| de Jesus, AA | 1 |
| Paray, AA | 1 |
| Flores, JD | 1 |
| Felizar, LB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Intravenous Infusion of Magnesium Sulfate Associated or Not to Lidocaine On the Neuromuscular Blockade Induced by Muscle Relaxant Cistracurium[NCT02483611] | Phase 4 | 48 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| "A Less-rapid Sequence Anesthetic Induction/Intubation Sequence? Does Apneic Oxygenation by Means of an Oxygenating Laryngoscope Blade Prolong the Duration of Apnea Without Desaturation in Paralyzed Non-obese and Morbidly Obese Patients?"[NCT02943629] | 0 participants (Actual) | Interventional | 2016-11-30 | Withdrawn (stopped due to Lack of feasibility) | |||
| The Effect of Intravenous Lidocaine on the Time Course of Rocuronium Induced Neuromuscular Block. A Randomised, Placebo-controlled, Electrophysiological Study[NCT00828373] | Phase 4 | 52 participants (Actual) | Interventional | 2009-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The clinical duration is the elapsed time for T1 recovery = 25% (Dur25%) of the original value of T1 after the infusion of cisatracurium.~This outcome meansure was presented in minutes." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | minutes (Median) |
|---|---|
| Group M | 82.68 |
| Group ML | 86.33 |
| Group C | 64.8 |
"The final recovery index is the elapsed time between the T1 recovery = 25% (Dur25%) and T4 / T1 = 80% (TOF = 80%) after the infusion of cisatracurium.~This outcome measure was presented in minutes." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | minutes (Mean) |
|---|---|
| Group M | 27.97 |
| Group ML | 33.81 |
| Group C | 21.51 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The measure of heart rate was recorded and annotated at various times such as in the arrival of the patient in the operating room. This time point was named as moment '1'. (NCT02483611)
Timeframe: This measure of heart rate was performed when the patient arrived in the operating room
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 79.94 |
| Group ML | 77.25 |
| Group C | 73.66 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as in the moment immediately before the anesthesia induction. This time point was named as moment '2'. (NCT02483611)
Timeframe: This measure of heart rate was performed immediately before induction of anesthesia
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 74.69 |
| Group ML | 73.69 |
| Group C | 75.40 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as immediately before the start of the infusion of the solution X (magnesium sulfate or isotonic solution) and Y solution (lidocaine or isotonic solution). This time point was named as moment '3'. (NCT02483611)
Timeframe: This measure of heart rate was performed immediately before the start of the infusion of the solution X (magnesium sulfate or isotonic solution) and Y solution (lidocaine or isotonic solution)
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 72.94 |
| Group ML | 74.19 |
| Group C | 75.40 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as in the end of the study solutions infusion. This time point was named as moment '4'. (NCT02483611)
Timeframe: This measure of heart rate was performed five minutes after M3 (in the end of the X and Y solutions infusion)
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 71.94 |
| Group ML | 72.25 |
| Group C | 65.07 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as immediately before the tracheal intubation. This time point was named as moment '5'. (NCT02483611)
Timeframe: This measure of heart rate was performed immediately before the tracheal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 67.56 |
| Group ML | 69.31 |
| Group C | 64.27 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as one minute after the tracheal intubation. This time point was named as moment '6'. (NCT02483611)
Timeframe: This measure of heart rate was performed one minute after the tracheal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 66.50 |
| Group ML | 68.19 |
| Group C | 65.13 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 15 minutes after the traqueal intubation.This time point was named as moment '7a'. (NCT02483611)
Timeframe: This measure of heart rate was performed 15 minutes after the traqueal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 68.94 |
| Group ML | 68.19 |
| Group C | 67.13 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 30 minutes after the traqueal intubation. This time point was named as moment '7b'. (NCT02483611)
Timeframe: This measure of heart rate was performed 30 minutes after the traqueal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 67.44 |
| Group ML | 68.38 |
| Group C | 64.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 45 minutes after the traqueal intubation. This time point was named as moment '7c'. (NCT02483611)
Timeframe: This measure of heart rate was performed 45 minutes after the traqueal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 65.75 |
| Group ML | 65.75 |
| Group C | 62.33 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 60 minutes after the traqueal intubation. This time point was named as moment '7d'. (NCT02483611)
Timeframe: This measure of heart rate was performed 60 minutes after the traqueal intubation
| Intervention | beats/min (Mean) |
|---|---|
| Group M | 66.19 |
| Group ML | 65.31 |
| Group C | 61.93 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 75 minutes after the traqueal intubation. This time point was named as moment '7e'. (NCT02483611)
Timeframe: This measure of heart rate was performed 75 minutes after the traqueal intubation
| Intervention | beats/min (Median) |
|---|---|
| Group M | 66.50 |
| Group ML | 63.00 |
| Group C | 58.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The heart rate was recorded and annotated at various times such as 90 minutes after the traqueal intubation. This time point was named as moment '7f'. (NCT02483611)
Timeframe: This measure of heart rate was performed 90 minutes after the traqueal intubation
| Intervention | beats/min (Median) |
|---|---|
| Group M | 66.00 |
| Group ML | 61.00 |
| Group C | 61.00 |
"The latency is computed as the elapsed time to reduce the response of T1 to 5% of the initial contraction force after the infusion of cisatracurium.~This outcome meansure was presented in seconds." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | seconds (Mean) |
|---|---|
| Group M | 139.70 |
| Group ML | 151.30 |
| Group C | 147.80 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as in the arrival of the patient in the operating room. This time point was named as moment '1'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed when the patient arrived in the operating room
| Intervention | mmHg (Mean) |
|---|---|
| Group M | 94.63 |
| Group ML | 88.75 |
| Group C | 100.10 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as in the moment immediately before the anesthesia induction. This time point was named as moment '2'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed immediately before induction of anesthesia
| Intervention | mmHg (Mean) |
|---|---|
| Group M | 87.63 |
| Group ML | 84.69 |
| Group C | 92.47 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as immediately before the start of the infusion of the solution X (magnesium sulfate or isotonic solution) and Y solution (lidocaine or isotonic solution). This time point was named as moment '3'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed immediately before the start of the infusion of the solution X (magnesium sulfate or isotonic solution) and Y solution (lidocaine or isotonic solution)
| Intervention | mmHg (Mean) |
|---|---|
| Group M | 75.88 |
| Group ML | 73.88 |
| Group C | 76.73 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as in the end of the study solutions infusion.This time point was named as moment '4'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed five minutes after M3 (in the end of the X and Y solutions infusion)
| Intervention | mmHg (Median) |
|---|---|
| Group M | 69.00 |
| Group ML | 63.00 |
| Group C | 74.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as immediately before the tracheal intubation. This time point was named as moment '5'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed immediately before the tracheal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 62.50 |
| Group ML | 61.50 |
| Group C | 67.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as one minute after the tracheal intubation. This time point was named as moment '6'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed one minute after the tracheal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 64.50 |
| Group ML | 64.00 |
| Group C | 69.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 15 minutes after the traqueal intubation. This time point was named as moment '7a'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 15 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 66.00 |
| Group ML | 61.50 |
| Group C | 69.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 30 minutes after the traqueal intubation. This time point was named as moment '7b'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 30 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 66.50 |
| Group ML | 63.50 |
| Group C | 68.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 45 minutes after the traqueal intubation. This time point was named as moment '7c'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 45 minutes after the traqueal intubation
| Intervention | mmHg (Mean) |
|---|---|
| Group M | 69.25 |
| Group ML | 63.00 |
| Group C | 69.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 60 minutes after the traqueal intubation. This time point was named as moment '7d'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 60 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 68.00 |
| Group ML | 62.00 |
| Group C | 66.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 75 minutes after the traqueal intubation. This time point was named as moment '7e'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 75 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 68.00 |
| Group ML | 66.00 |
| Group C | 69.00 |
In the operating room, patients were cardiovascular, respiratory and body temperature monitored through the Dixtal 2020. The mean blood pressure was recorded and annotated at various times such as 90 minutes after the traqueal intubation. This time point was named as moment '7f'. (NCT02483611)
Timeframe: This measure of average blood pressure was performed 90 minutes after the traqueal intubation
| Intervention | mmHg (Median) |
|---|---|
| Group M | 64.00 |
| Group ML | 64.50 |
| Group C | 72.00 |
"The recovery index is the elapsed time between the T1 recovery =25% (Dur25%) and T1 =75% (Dur75%) after the infusion of cisatracurium.~This outcome meansure was presented in minutes." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | minutes (Mean) |
|---|---|
| Group M | 20.08 |
| Group ML | 20.26 |
| Group C | 14.53 |
"Spontaneous recovery is the elapsed time for the recovery of the TOF (T4 / T1) response to 90% of the original after infusion of cisatracurium.~This outcome measure was presented in minutes." (NCT02483611)
Timeframe: The participants were followed during the anesthetic - surgical procedure
| Intervention | minutes (Mean) |
|---|---|
| Group M | 120.20 |
| Group ML | 126.70 |
| Group C | 90.03 |
"The total duration is the elapsed time for T1 recovery of the response to reach 95% of the initial after the infusion of cisatracurium.~This outcome measure was presented in minutes." (NCT02483611)
Timeframe: Participants were followed during the anesthetic - surgical procedure, an average of 90 minutes
| Intervention | minutes (Mean) |
|---|---|
| Group M | 113.20 |
| Group ML | 120.10 |
| Group C | 88.19 |
13 trials available for lidocaine and Neuromuscular Blockade
| Article | Year |
|---|---|
Lidocaine combined with magnesium sulfate preserved hemodynamic stability during general anesthesia without prolonging neuromuscular blockade: a randomized, double-blind, controlled trial.
Topics: Adult; Analgesics; Anesthesia, General; Anesthetics, Local; Arterial Pressure; Atracurium; Double-Bl | 2021 |
Neuromuscular blockade with atracurium for ophthalmic surgery in horses-Effects on surgical and anesthetic characteristics and recovery quality.
Topics: Animals; Atracurium; Eye Diseases; Horse Diseases; Horses; Lidocaine; Neuromuscular Blockade; Neurom | 2021 |
Effect of suxamethonium vs rocuronium on onset of oxygen desaturation during apnoea following rapid sequence induction.
Topics: Adult; Androstanols; Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Apnea; Fasci | 2010 |
Effect of an intravenous infusion of lidocaine on cisatracurium-induced neuromuscular block duration: a randomized-controlled trial.
Topics: Adult; Aged; Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Intravenous; Anesthetics, | 2010 |
Two-quadrant high-volume sub-Tenon's anaesthesia for vitrectomy: a randomised controlled trial.
Topics: Aged; Anesthesia, Local; Anesthetics, Combined; Anesthetics, Local; Bupivacaine; Female; Humans; Hya | 2012 |
Comparison between single-injection inferomedial and inferotemporal peribulbar blockades before cataract surgery.
Topics: Aged; Anesthesia, Local; Anesthetics, Combined; Anesthetics, Local; Bupivacaine; Cataract Extraction | 2012 |
Intravenous lidocaine has no impact on rocuronium-induced neuromuscular block. Randomised study.
Topics: Adult; Androstanols; Anesthetics, Local; Female; Humans; Injections, Intravenous; Lidocaine; Male; M | 2012 |
Intravenous lidocaine has no impact on rocuronium-induced neuromuscular block. Randomised study.
Topics: Adult; Androstanols; Anesthetics, Local; Female; Humans; Injections, Intravenous; Lidocaine; Male; M | 2012 |
Intravenous lidocaine has no impact on rocuronium-induced neuromuscular block. Randomised study.
Topics: Adult; Androstanols; Anesthetics, Local; Female; Humans; Injections, Intravenous; Lidocaine; Male; M | 2012 |
Intravenous lidocaine has no impact on rocuronium-induced neuromuscular block. Randomised study.
Topics: Adult; Androstanols; Anesthetics, Local; Female; Humans; Injections, Intravenous; Lidocaine; Male; M | 2012 |
Comparison of metal and flexible sub-Tenon cannulas.
Topics: Anesthesia, Local; Anesthetics, Combined; Anesthetics, Local; Bupivacaine; Catheters; Double-Blind M | 2012 |
[Pretreatment with lidocaine accelerates onset of vecuronium-induced neuromuscular blockade].
Topics: Adolescent; Aged; Anesthesia, General; Double-Blind Method; Drug Interactions; Female; Humans; Injec | 2002 |
Does pregnancy increase the efficacy of lumbar epidural anesthesia?
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthetics, Local; Cesarean Section; Female; | 2004 |
A comparison of epidural blockade produced by plain 1% lidocaine and 1% lidocaine prepared by dilution of 2% lidocaine with the same volume of saline.
Topics: Anesthesia, Epidural; Anesthetics, Local; Blood Pressure; Double-Blind Method; Female; Gynecologic S | 2006 |
Sub-Tenon's block: the effect of hyaluronidase on speed of onset and block quality.
Topics: Aged; Anesthetics, Local; Bupivacaine; Cataract Extraction; Double-Blind Method; Female; Humans; Hya | 1999 |
Ropivacaine-lidocaine versus bupivacaine-lidocaine for retrobulbar anesthesia in cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Amides; Anesthesia, Local; Anesthetics, Combined; Anesthetics, Local | 2002 |
10 other studies available for lidocaine and Neuromuscular Blockade
| Article | Year |
|---|---|
Onset and duration of cis-atracurium neuromuscular block during fentanyl and lidocaine infusions in isoflurane-anaesthetised dogs.
Topics: Anesthesia, Inhalation; Animals; Atracurium; Dogs; Female; Fentanyl; Infusions, Intravenous; Isoflur | 2020 |
The Effect of Depressor Anguli Oris Muscle Block on Facial Symmetry in Synkinetic Facial Paralysis Patients and Its Role in Preoperative Assessment.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Facial Asymmetry; Facial Expression; Facial Muscles; | 2021 |
Intraoperative mandibular nerve block with peripheral nerve stimulator for temporomandibular joint ankylosis.
Topics: Androstanols; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Anesthetics, L | 2016 |
The importance of staying current on rapid sequence intubation.
Topics: Anesthetics, Intravenous; Anesthetics, Local; Glasgow Coma Scale; Humans; Hypnotics and Sedatives; I | 2010 |
Intrathecal ropivacaine in rabbits: pharmacodynamic and neurotoxicologic study.
Topics: Amides; Anesthetics, Local; Animals; Dose-Response Relationship, Drug; Evoked Potentials, Somatosens | 2002 |
Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anesthetics, Local; Central Nervou | 2002 |
Neuromuscular block with lignocaine.
Topics: Analgesia; Anesthesia; Anesthesia and Analgesia; Anesthesia, Conduction; Humans; Lidocaine; Neuromus | 1958 |
[Influence of epidural lidocaine injection on vecuronium-induced neuromuscular blockade].
Topics: Adult; Aged; Anesthesia, General; Anesthetics, Local; Drug Synergism; Female; Humans; Injections, Ep | 2004 |
Intubation success rates improve for an air medical program after implementing the use of neuromuscular blocking agents.
Topics: Adjuvants, Anesthesia; Adult; Air Ambulances; Anesthesia, Intravenous; Anesthetics, Local; Atropine; | 1998 |
Spinal tonicaine: potency and differential blockade of sensory and motor functions.
Topics: Analysis of Variance; Anesthetics, Local; Animals; Cells, Cultured; Injections, Spinal; Lidocaine; M | 2000 |